Optimization of the entrapment of bacterial cell envelope extracts into microparticles for vaccine delivery

被引:7
作者
Estevan, Maite [1 ]
Gamazo, Carlos
Gonzalez-Gaitano, Gustavo
Irache, Juan M.
机构
[1] Univ Navarra, Dept Microbiol, Pamplona 31008, Spain
[2] Univ Navarra, Dept Physicochem, Pamplona 31008, Spain
[3] Univ Navarra, Dept Pharmaceut Technol, Pamplona 31008, Spain
关键词
Brucellosis; microparticles; poly (epsilon-caprolactone); vaccine; TROMS;
D O I
10.1080/02652040500435253
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The encapsulation of a Brucella ovis extract (HS) in microparticles has been proved effective against experimental infections in mice. This work describes different strategies to increase the HS loading and prepare large batches as necessary to test this vaccine in ovine. The mixture of HS with beta-cyclodextrin was optimized in order to increase the HS loading in microparticles. On the other hand, TROMS ('Total Recirculation One-Machine System') led microparticles with a more homogeneous size than the laboratory or standard procedure. Moreover, the initial burst release of HS from the standard microparticles was higher than for the TROMS ones. In fact, standard microparticles displayed a higher amount of adsorbed HS. On the contrary, both preparative methods were found effective to preserve the integrity and anti-genicity of the loaded HS. In summary, beta-CD can be used to increase the loading of large hydrophobic materials and TROMS is a valid large production of antigen-loaded microparticles.
引用
收藏
页码:169 / 181
页数:13
相关论文
共 31 条
[1]   Encapsulation of insulin-cyclodextrin complex in PLGA microspheres: a new approach for prolonged pulmonary insulin delivery [J].
Aguiar, MMG ;
Rodrigues, JM ;
Cunha, AS .
JOURNAL OF MICROENCAPSULATION, 2004, 21 (05) :553-564
[2]   BIODEGRADABLE MICROSPHERES AS CONTROLLED-RELEASE TETANUS TOXOID DELIVERY SYSTEMS [J].
ALONSO, MJ ;
GUPTA, RK ;
MIN, C ;
SIBER, GR ;
LANGER, R .
VACCINE, 1994, 12 (04) :299-306
[3]   Adjuvants designed for veterinary and human vaccines [J].
Aucouturier, J ;
Dupuis, L ;
Ganne, V .
VACCINE, 2001, 19 (17-19) :2666-2672
[4]   Identification of the Brucella melitensis vaccine strain Rev.1 in animals and humans in Israel by PCR analysis of the PstI site polymorphism of its omp2 gene [J].
Bardenstein, S ;
Mandelboim, M ;
Ficht, TA ;
Baum, M ;
Banai, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) :1475-1480
[5]   Preparation and characterization of protein-loaded poly(ε-caprolactone) microparticles for oral vaccine delivery [J].
Benoit, MA ;
Baras, B ;
Gillard, J .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (01) :73-84
[6]   Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres [J].
Berkland, C ;
Kipper, MJ ;
Narasimhan, B ;
Kim, KK ;
Pack, DW .
JOURNAL OF CONTROLLED RELEASE, 2004, 94 (01) :129-141
[7]   PLG microsphere size controls drug release rate through several competing factors [J].
Berkland, C ;
Kim, K ;
Pack, DW .
PHARMACEUTICAL RESEARCH, 2003, 20 (07) :1055-1062
[8]   BRUCELLA-MELITENSIS REV-1 VACCINE AS A CAUSE OF HUMAN BRUCELLOSIS [J].
BLASCO, JM ;
DIAZ, R .
LANCET, 1993, 342 (8874) :805-805
[9]   The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method [J].
Coombes, AGA ;
Yeh, MK ;
Lavelle, EC ;
Davis, SS .
JOURNAL OF CONTROLLED RELEASE, 1998, 52 (03) :311-320
[10]  
DEBAGUES MPJ, 1989, ANN RECH VET, V20, P205